Cargando…

Outcomes associated with the intention of loco-regional therapy prior to living donor liver transplantation for hepatocellular carcinoma

BACKGROUND: Loco-regional therapy for hepatocellular carcinoma (HCC) during the period awaiting liver transplantation (LT) appears to be a logical approach to reduce the risk of tumor progression and dropout in the waitlist. Living donor LT (LDLT) offers a flexible timing for transplantation providi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Tsung-Han, Wang, Yu-Chao, Cheng, Chih-Hsien, Lee, Chen-Fang, Wu, Ting-Jung, Chou, Hong-Shiue, Chan, Kun-Ming, Lee, Wei-Chen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2020
Materias:	Retrospective Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6943093/ https://www.ncbi.nlm.nih.gov/pubmed/31984121 http://dx.doi.org/10.4240/wjgs.v12.i1.17

Ejemplares similares

Living-Donor Liver Transplantation for Hepatocellular Carcinoma: Impact of the MELD Score and Predictive Value of NLR on Survival
por: Hung, Hao-Chien, et al.
Publicado: (2022)

Adult Living Donor Liver Transplantation Across ABO-Incompatibility
por: Lee, Chen-Fang, et al.
Publicado: (2015)

Salvage living donor liver transplantation for posthepatectomy recurrence: a higher incidence of recurrence but promising strategy for long-term survival
por: Chan, Kun-Ming, et al.
Publicado: (2019)

Modified preoperative score to predict disease-free survival for hepatocellular carcinoma patients with surgical resections
por: Lai, Yin, et al.
Publicado: (2022)

Impact of donor with evidence of bacterial infections on deceased donor liver transplantation: a retrospective observational cohort study in Taiwan
por: Chan, Kun-Ming, et al.
Publicado: (2019)

Clinical Relevance of Isoagglutinin Rebound in Adult ABO-Incompatible Living Donor Liver Transplantation
por: Lee, Wei-Chen, et al.
Publicado: (2021)

Advantage of early liver transplantation whenever indicated for hepatocellular carcinoma recurrence after primary liver resection
por: Chan, Kun-Ming, et al.
Publicado: (2019)

Efficacy of loco-regional treatment for hepatocellular carcinoma prior to living donor liver transplantation: a report from a single center in Egypt
por: Shaker, Mohammad Kamal, et al.
Publicado: (2018)

Encouraging Split Liver Transplantation for Two Adult Recipients to Mitigate the High Incidence of Wait-List Mortality in the Setting of Extreme Shortage of Deceased Donors
por: Chan, Kun-Ming, et al.
Publicado: (2019)

Preferred Treatment with Curative Intent for Left Lateral Segment Early Hepatocellular Carcinoma under the Era of Minimal Invasive Surgery
por: Wu, Tsung-Han, et al.
Publicado: (2022)

Implementation of sorafenib treatment for advanced hepatocellular carcinoma: an illustration of current practice in Taiwan
por: Chan, Kun-Ming, et al.
Publicado: (2019)

Reconstruction of Separated Intrahepatic Ducts Using the Cystic and Common Hepatic Ducts in Right-Lobe Living-Donor Liver Transplantation: Experiences of Surgical Techniques, Biliary Complications, and Outcomes in a Single Institution
por: Hsu, Po-Jung, et al.
Publicado: (2022)

Pediatric living donor liver transplantation decade progress in Shanghai: Characteristics and risks factors of mortality
por: Pan, Zhi-Ying, et al.
Publicado: (2020)

Outcomes of right-lobe and left-lobe living-donor liver transplantations using small-for-size grafts
por: She, Wong Hoi, et al.
Publicado: (2017)

“Left at right” liver transplantation with heterotopic implantation of left liver graft in the right subphrenic space: Reappraisal and technical concerns for decision making
por: Chan, Kun-Ming, et al.
Publicado: (2019)

Risk factors for myocardial injury during living donor liver transplantation in pediatric patients with biliary atresia
por: Wu, Yu-Li, et al.
Publicado: (2023)

Elevation of Lipid Metabolites in Deceased Liver Donors Reflects Graft Suffering
por: Lee, Wei-Chen, et al.
Publicado: (2023)

Myeloid-derived suppressor cells in the patients with liver resection for hepatitis B virus-related hepatocellular carcinoma
por: Lee, Wei-Chen, et al.
Publicado: (2019)

Clinical relevance of alpha-fetoprotein in determining resection margin for hepatocellular carcinoma
por: Lee, Jin-Chiao, et al.
Publicado: (2019)

Biliary complications in recipients of living donor liver transplantation: A single-centre study
por: Guirguis, Reginia Nabil, et al.
Publicado: (2021)

Renal Function Improvement by Telbivudine in Liver Transplant Recipients with Chronic Kidney Disease
por: Lee, Wei-Chen, et al.
Publicado: (2017)

Sedative and Immunosuppressive Effects of Dexmedetomidine in Transplantation
por: Lee, Chen-Fang, et al.
Publicado: (2021)

Improving outcomes of liver resection for hepatocellular carcinoma associated with portal vein tumor thrombosis over the evolving eras of treatment
por: Wang, Yu-Chao, et al.
Publicado: (2021)

Effects of Converting Tacrolimus Formulation from Twice-Daily to Once-Daily in Liver Transplantation Recipients
por: Thorat, Ashok, et al.
Publicado: (2014)

Response Prediction in Immune Checkpoint Inhibitor Immunotherapy for Advanced Hepatocellular Carcinoma
por: Hung, Hao-Chien, et al.
Publicado: (2021)

Loco-Regional Treatments for Hepatocellular Carcinoma in People Living with HIV
por: Micali, Cristina, et al.
Publicado: (2022)

Significance of Hepatitis B Recurrence in Liver Transplantation Recipients
por: Chou, Hong-Shiue, et al.
Publicado: (2020)

Treatment strategy of adding transcatheter arterial chemoembolization to sorafenib for advanced stage hepatocellular carcinoma
por: Lee, Wei‐Chen, et al.
Publicado: (2020)

Risk Score Model for Microvascular Invasion in Hepatocellular Carcinoma: The Role of Tumor Burden and Alpha-Fetoprotein
por: Lee, Jin-Chiao, et al.
Publicado: (2021)

Impact of biliary complications on quality of life in live-donor liver transplant recipients
por: Guirguis, Reginia Nabil, et al.
Publicado: (2021)

Preemptive living donor kidney transplantation: Access, fate, and review of the status in Egypt
por: Gadelkareem, Rabea Ahmed, et al.
Publicado: (2023)

Living donor liver transplantation for Barcelona clinic liver cancer (BCLC) intermediate-stage hepatocellular carcinoma
por: Tsai, Ming Chao, et al.
Publicado: (2022)

Protein S for Portal Vein Thrombosis in Cirrhotic Patients Waiting for Liver Transplantation
por: Hung, Hao-Chien, et al.
Publicado: (2020)

Recurrence Patterns After Hepatectomy With Very Narrow Resection Margins for Hepatocellular Carcinoma
por: Cheng, Chih-Hsien, et al.
Publicado: (2022)

Converting from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in Patients with Hepatitis B Following Liver Transplantation
por: Cheng, Chih-Hsien, et al.
Publicado: (2023)

A review of split liver transplantation with full right/left hemi-liver grafts for 2 adult recipients
por: Chan, Kun-Ming, et al.
Publicado: (2021)

Human Cytomegalovirus Is Associated with Lower HCC Recurrence in Liver Transplant Patients
por: Hsu, Po-Jung, et al.
Publicado: (2021)

Plasma cytomegalovirus DNA load predicts outcomes in liver transplant recipients
por: Hung, Hao‐Chien, et al.
Publicado: (2020)

Perioperative blood transfusion decreases long-term survival in pediatric living donor liver transplantation
por: Gordon, Karina, et al.
Publicado: (2021)

De Novo Endotoxin-Induced Production of Antibodies against the Bile Salt Export Pump Associated with Bacterial Infection following Major Hepatectomy
por: Chan, Kun-Ming, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_hd33k6f1t9d3s035r9n1shcmfq